Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Salion GmbH manages a patent portfolio within the Chemistry & Materials technology area. The portfolio currently has 1 pending office action. This prosecution activity is handled by 1 distinct examiner and is located within 1 distinct art unit, showing a very focused interaction with the patent office at this time. The use of 1 distinct art unit indicates that the technical review for the Chemistry & Materials portfolio is centralized within a single administrative group.
The busiest examiner for Salion GmbH is COLENA, TRACY CHING-TIAN, who is responsible for 1 busiest examiner pending action. Because there is only 1 pending office action in total, this examiner oversees the entire active workload for the portfolio. Success in these proceedings depends on addressing the specific concerns of this 1 distinct examiner and the requirements of COLENA, TRACY CHING-TIAN. The company must focus its resources on this matter to ensure the 1 pending office action reaches a favorable conclusion.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMATO JR, DENNIS IGNATIUS | 1 | 40.9% | +81.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909840 | DETECTION OF KLOTHO | ARMATO JR, DENNIS IGNATIUS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17909840 | DETECTION OF KLOTHO | ARMATO JR, DENNIS IGNATIUS | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17909840 | DETECTION OF KLOTHO | ARMATO JR, DENNIS IGNATIUS | 1651 | §101§103§112 | Final Rejection | — | Pending | Sep 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSalion GmbH has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Dennis Ignatius Armato Jr. has the most, with 1 of Salion GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.